Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturationMitsutoshi Matsuo, Yasuhiro Nagata, Eiichi Sato, et al.Cancer Research|April 4, 2002
Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8+ Tumor-reactive T-Cell Ligands: a comparative analysis of PS-SCL recognition by a single tumor-reactive CD8+ cytolytic T-lymphocyte cloneVerena Rubio-Godoy, Clemencia Pinilla, Valerie Dutoit, et al.Cancer Research|May 19, 2006
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responsesLaurence Chapatte, Maha Ayyoub, Sandra Morel, et al.Cancer Research|January 19, 2012
Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivoAhmed Hamaï, Pascale Pignon, Isabelle Raimbaud, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTLVerena Rubio-Godoy, Valérie Dutoit, Yingdong Zhao, et al.Cancer Immunity|October 29, 2003
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccineDanila Valmori, Valérie Dutoit, Maha Ayyoub, et al.Journal of Immunological Methods|July 24, 2002
Findings on T cell specificity revealed by synthetic combinatorial librariesEva Borràs, Roland Martin, Valeria Judkowski, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCsSacha Gnjatic, Djordje Atanackovic, Mitsutoshi Matsuo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1Maha Ayyoub, Alfred Zippelius, Mikaël J Pittet, et al.European Journal of Immunology|June 12, 2008
Lentivector immunization induces tumor antigen-specific B and T cell responses in vivoJavier Garcia Casado, Jozef Janda, Joe Wei, et al.Pageof 8